Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000927016-02-001731
Filing Date
2002-03-29
Accepted
2002-03-29 00:00:00
Documents
10
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K405 d10k405.txt 10-K405 371761
3 SEVERANCE AGREEMENT 11/5/01 W/ ANDREW UPRICHARD dex1044.txt EX-10.44 9206
4 PROMISSORY NOTE DATED 8/3/01 dex1045.txt EX-10.45 2560
5 LETTER TO DOROS PLATIKA 1/28/2002 dex1046.txt EX-10.46 27220
6 LETTER DATED 3/12/2002 dex1047.txt EX-10.47 1657
7 LETTER TO GEORGE ELDRIDGE 3/6/2002 dex1048.txt EX-10.48 27968
8 SUBSIDIARIES OF CURIS dex21.txt EX-21 424
9 CONSENT OF ARTHUR ANDERSEN LLP dex231.txt EX-23.1 891
10 CONSENT OF DELLOITE & TOUCHE dex232.txt EX-23.2 756
11 LETTER TO COMMISSION dex991.txt EX-99.1 1663
  Complete submission text file 0000927016-02-001731.txt   446700
Mailing Address 61 MOULTON ST CAMBRIDGE MA 02138
Business Address 61 MOULTON ST CAMBRIDGE MA 02138 6178760086
CURIS INC (Filer) CIK: 0001108205 (see all company filings)

EIN.: 043505116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-30347 | Film No.: 02592441
SIC: 2836 Biological Products, (No Diagnostic Substances)